TriSalus Life Sciences (TLSI) Shares Outstanding (Weighted Average) (2020 - 2026)

TriSalus Life Sciences (TLSI) has 7 years of Shares Outstanding (Weighted Average) data on file, last reported at $51.5 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) rose 80.67% year-over-year to $51.5 million; the trailing twelve-month figure through Mar 2026 stood at $51.5 million (up 80.67% YoY), and the FY2025 full-year result was $37.9 million, up 418.35% from the prior year.
• Shares Outstanding (Weighted Average) for Q1 2026 stood at $51.5 million, up from $7.4 million in the prior quarter.
• Across five years, Shares Outstanding (Weighted Average) topped out at $51.5 million in Q1 2026 and bottomed at $299936.0 in Q3 2022.
• The 5-year median for Shares Outstanding (Weighted Average) is $7.4 million (2025), against an average of $13.8 million.
• The widest annual swing landed in 2022, when Shares Outstanding (Weighted Average) sank 98.8%; it then surged 2574.92% in 2023.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $309609.0 in 2022, then soared by 2574.92% to $8.3 million in 2023, then slipped by 11.72% to $7.3 million in 2024, then increased by 1.25% to $7.4 million in 2025, then soared by 596.24% to $51.5 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $51.5 million (Q1 2026), $7.4 million (Q4 2025), and $7.4 million (Q3 2025), per Business Quant data.

Peer Comparison